Congenital Heart Disease Financial Planning: SNT Strategy, Surgical Reserves, and Adult CHD Care
More than 2 million Americans are living with congenital heart disease (CHD) — and that population grows every year as children who once would not have survived infancy reach adulthood with complex cardiac anatomy and lifelong medical needs. For families of children with complex CHD, financial planning involves three parallel tracks that most advisors have never navigated: sizing and funding a Special Needs Trust around a lifetime of cardiac interventions; securing life insurance before the medical record makes coverage impossible or unaffordable; and connecting an adult child to the vanishingly small network of specialists who actually understand grown-up congenital hearts. For adults with CHD who work, a fourth track — protecting Medicaid access through Section 1619(b) — can mean the difference between coverage and a coverage gap that coincides with a cardiac intervention costing six figures.
The CHD spectrum: financial implications by diagnosis category
Congenital heart disease is not one condition but a spectrum of ~40 distinct structural defects with wildly different functional consequences. A small patent foramen ovale (PFO) requires minimal intervention and creates no long-term disability. Hypoplastic left heart syndrome (HLHS) requires three open-heart operations in the first few years of life and creates lifelong single-ventricle circulation that inevitably deteriorates. The financial plan for a child with CHD must be calibrated to where on that spectrum the child sits — and to the trajectory of their condition over decades, not just their current clinical status.2
| CHD category | Representative diagnoses | Key financial planning focus |
|---|---|---|
| Simple / low complexity | Small ASD, small VSD, bicuspid aortic valve, PFO | Life insurance before complications appear (bicuspid AV → aortic stenosis by 50s); ABLE account for medical expenses if on SSI; periodic echocardiogram reserve in budget |
| Moderate complexity | Tetralogy of Fallot (repaired), large ASD, coarctation of aorta, pulmonary stenosis | Pulmonary valve replacement reserve ($80K–$200K+ per procedure, often needed every 10–20 years); ACHD specialist travel costs; SSA Listing 4.06 evaluation if symptoms progress; life insurance while functional capacity is good |
| Great complexity — biventricular | Transposition of great arteries (repaired), AV canal defect, truncus arteriosus | Lifelong ACHD specialist follow-up; SNT for adults who cannot maintain SGA-level employment; SSI/SSDI qualification under Listing 4.06 or 4.02 (heart failure); neurodevelopmental comorbidities (25–35% incidence) require additional SNT planning |
| Single-ventricle / Fontan circulation | HLHS, tricuspid atresia, heterotaxy with functional single ventricle, unbalanced AV canal | HLHS on SSA Compassionate Allowance (CAL) list — ~10-day SSDI/SSI approval; Fontan-associated liver disease requiring surveillance and potential heart-liver transplant; SNT sized to multi-decade complex care trajectory; life insurance often unavailable in adulthood; Medicaid preservation essential |
SSA disability pathways for CHD
Hypoplastic left heart syndrome: Compassionate Allowance fast-track
HLHS is included on SSA's Compassionate Allowances (CAL) list, enabling disability determination in approximately 10 days with sufficient medical documentation.3 For a newborn or infant with HLHS, SSI should be applied for immediately after diagnosis — even before the first surgery. A benefits counselor can calculate whether the child's SSI cash payment will be $0 due to parental income; this is common for middle-income families. Even with no cash payment, the Medicaid that attaches to SSI eligibility is worth establishing, because Medicaid will be the primary payer for surgical hospitalizations that can cost $200,000–$500,000+ per episode in a high-resource HLHS case. Establishing the SSI record early also creates the foundation for a transition to adult SSI at age 18 when parental income deeming ends.
SSA Blue Book Listing 4.06: symptomatic congenital heart disease (adults)
For adults with CHD whose condition does not involve the simple cyanosis pathway, SSA evaluates congenital heart disease under Listing 4.06 using the following framework (revised 2022, effective 2023):4
- Pathway A — Cyanosis at rest: Hematocrit ≥55% on two separate measurements at least 90 days apart within a consecutive 12-month period, OR arterial oxygen saturation <90% on room air on two separate measurements at least 90 days apart within a consecutive 12-month period
- Pathway B — Exercise intolerance with shunting: Intermittent right-to-left shunting causing hypoxemia on exertion, documented by exercise testing showing inability to perform at ≤5 METs with prescribed criteria
- Pathway C — Pulmonary vascular obstructive disease: Secondary pulmonary vascular obstructive disease with pulmonary arterial systolic pressure ≥70 mm Hg documented on cardiac catheterization or right-heart echocardiography
If CHD has resulted in chronic heart failure with ventricular dysfunction, SSA evaluates under Listing 4.02 instead. If recurrent arrhythmias are the primary issue, Listing 4.05 applies. Many adults with complex repaired CHD who do not meet 4.06's specific criteria will instead be evaluated via residual functional capacity (RFC) — an individualized assessment of what they can actually do — which can still result in disability approval if cardiac limitations prevent full-time sedentary work.
Children: Listing 104.06 and neurodevelopmental pathways
Children with CHD are evaluated under Section 104.06 (cardiovascular listings for children), which applies similar cyanosis and exercise-intolerance criteria adapted for pediatric norms.5 However, one of the most underplanned aspects of CHD in children is the neurodevelopmental impact of cardiac surgery itself. Approximately 25–35% of children who undergo open-heart surgery requiring cardiopulmonary bypass develop measurable cognitive or developmental delays — a consequence of bypass-associated inflammation, embolic events, and reduced cerebral perfusion.2 For these children, SSA qualification may flow through neurodevelopmental listings (12.05 for intellectual disorder, 12.11 for neurodevelopmental disorders, or 12.02 for neurocognitive disorders from brain injury) rather than or in addition to the cardiovascular listings. A special needs financial planner must account for both the cardiac care trajectory and the neurodevelopmental needs in the same SNT.
Surgical cost planning: Fontan palliation and adult CHD interventions
For families of children with single-ventricle anatomy, the first decade of life involves a staged surgical series that most families understand but few have financially modeled across its full lifetime trajectory. For families of children with moderate-complexity CHD (repaired tetralogy of Fallot, transposition, coarctation), the important cost planning is about the reinterventions that happen in adulthood — often 20–40 years after the initial repair, sometimes beginning in the 20s or 30s.
The three-stage Fontan palliation
HLHS and other single-ventricle diagnoses are managed through a sequence of three palliative operations that redirect blood flow to compensate for having one functional ventricle. Each requires a hospital stay that typically runs two to four weeks for complex cases:
| Stage | Typical timing | Procedure | Estimated total hospital cost |
|---|---|---|---|
| Stage I | First week of life | Norwood procedure (or Hybrid) — the most complex neonatal cardiac operation | $200,000 – $500,000+ |
| Stage II | Ages 4–6 months | Bidirectional Glenn shunt | $100,000 – $250,000 |
| Stage III | Ages 2–4 years | Fontan completion (lateral tunnel or extracardiac conduit) | $100,000 – $250,000 |
| Total first 4 years | Three surgeries plus ICU, step-down, and follow-up hospitalizations | $400,000 – $1,000,000+ |
After the Fontan completion, the child enters a period of relative stability — but the single-ventricle physiology creates a pressure gradient that produces systemic venous hypertension, which over 10–20 years causes progressive liver damage (Fontan-associated liver disease, covered below) and eventual cardiovascular deterioration that may require Fontan conversion surgery, cardiac catheterization-based interventions, or transplantation.
Adult CHD reinterventions: the costs that surprise families
Children with moderate-complexity CHD — repaired tetralogy of Fallot, for instance — often have good functional status in their 20s and minimal medical costs. Then their pulmonary valve, which was implanted during childhood repair, begins to fail. Pulmonary valve replacement in adulthood runs $80,000–$200,000+ per procedure and is frequently needed every 10–25 years depending on whether a surgical or transcatheter approach is used.6 The complete adult CHD reintervention cost profile across the lifespan includes:
- Pulmonary valve replacement — $80K–$200K per procedure; transcatheter options (TPVR) may reduce surgical risk but require specific anatomic criteria
- Cardiac catheterizations — $30K–$80K per procedure for diagnostic or interventional cath; many CHD adults need these every 2–5 years
- Arrhythmia ablation and pacemaker implantation — $50K–$150K depending on complexity; common in adults with repaired Fallot, d-TGA, or single-ventricle anatomy
- Aortic intervention — for bicuspid aortic valve, coarctation sequelae, or Marfan/HTAD overlap; $100K–$300K+ for surgical aortic root replacement
- Heart transplantation (Fontan failure) — $500K–$1M+ for the transplant hospitalization; $30K–$50K/year ongoing immunosuppression; not always available due to Fontan-associated liver damage precluding isolated cardiac transplant
Fontan-associated liver disease: the long-term planning problem no one explains
Every person who has undergone Fontan palliation will develop some degree of liver fibrosis. This is not a complication that happens to some Fontan patients — it is a universal consequence of the elevated systemic venous pressure that the Fontan circulation creates.7 The liver bears the chronic backpressure, progressively developing fibrosis, cirrhosis, and in 1.5–5% of cases per year, hepatocellular carcinoma (HCC) — one of the most aggressive cancers.
The financial planning implications of Fontan-associated liver disease (FALD) are underestimated by nearly every family until a Fontan adult in their 20s or 30s develops severe liver disease:
- Liver surveillance — annual or semi-annual MRI/elastography/labs; ~$1,500–$5,000/year OOP depending on insurance and access to Fontan clinics; most major ACHD programs have dedicated Fontan liver surveillance protocols
- Hepatocellular carcinoma treatment — surgical resection $100K–$300K+; ablation $50K–$150K; sorafenib or other systemic therapy $50K–$100K/year; liver transplant if HCC is detected early enough
- Combined heart-liver transplantation — for patients whose Fontan failure and liver disease are both too advanced for isolated organ transplant; this highly complex surgery is performed at only a handful of U.S. centers and costs $1M–$2M+ for the combined hospitalization; long-term survival data is improving but remains less certain than isolated heart transplant
- Geographic access — major ACHD programs with Fontan liver expertise are concentrated at academic centers (Boston Children's, Cleveland Clinic, Mayo, CHOP, Texas Children's, Stanford); travel and lodging for surveillance, procedures, and transplant evaluation must be budgeted for families not near these centers
Life insurance and disability insurance: the access problem
The ACA eliminated pre-existing condition exclusions for health insurance — a CHD child or adult cannot be denied health coverage or charged higher premiums based on their cardiac history. But life insurance and long-term disability insurance are not covered by the ACA, and insurers in those markets can and do use health history to decline applicants or charge rated premiums.
The practical reality for CHD families and adults:
- Simple CHD (repaired ASD, small VSD with no residual shunt) — usually insurable at standard or mildly rated premiums for life and LTD. Apply after repair is confirmed stable. Do not wait.
- Moderate complexity (repaired Fallot, coarctation, d-TGA with good ventricular function) — many applicants can get individual life insurance at 2–4× standard rates during periods of good clinical status; group life through an employer is the most accessible and typically does not require individual medical underwriting up to a guaranteed issue limit ($100K–$500K depending on the plan). This may be the only life insurance accessible as cardiac status changes in middle age.
- Complex CHD (single-ventricle, Fontan circulation, cyanotic adults, severe ventricular dysfunction) — traditional individual life insurance is typically unavailable or priced prohibitively. Group employer life insurance remains accessible. Guaranteed-issue life insurance (no underwriting, typically small face amounts of $10K–$25K) is available but not a meaningful funding vehicle for an SNT. For families of children with complex CHD, parental life insurance — survivorship policies naming the SNT as beneficiary — is the primary SNT funding strategy, because the child cannot be insured for a meaningful amount but the parents can.
- Long-term disability insurance — for adults with moderate CHD who work, securing individual LTD before clinical deterioration is an immediate planning priority. Group LTD through an employer is available without medical underwriting during open enrollment windows; once a cardiac event triggers a claim, individual LTD becomes unavailable. The window closes faster than most CHD adults realize.
Survivorship life insurance as the SNT funding vehicle
For parents of children with complex CHD, the conventional financial planning approach — naming the child as beneficiary on individual life policies — creates the same SSI/Medicaid destruction problem as any direct inheritance. The correct structure is:
- Parents establish a third-party Special Needs Trust naming the child as sole beneficiary
- Parents obtain survivorship life insurance (second-to-die) naming the SNT as beneficiary — this policy pays on the death of the second parent and is typically less expensive than two individual policies because it only pays once
- Grandparents, aunts, uncles update their wills and beneficiary designations to route any inheritance to the same SNT, not to the child directly
If a parent has CHD themselves (genetic or hereditary CHD accounts for ~8% of cases2), survivorship policy underwriting takes both parents' health into account. An insurance broker who specializes in impaired-risk life insurance should be consulted before applying, to identify carriers with the most favorable CHD underwriting standards.
Section 1619(b): Medicaid protection for working CHD adults
Many adults with moderate-complexity CHD work full-time and earn above the Substantial Gainful Activity level ($1,690/month in 2026). For those who originally qualified for SSI due to CHD and are now working, Section 1619(b) allows earnings above SGA while keeping full Medicaid coverage — as long as the person's earnings are below their state's 1619(b) threshold, which ranges from approximately $29,000 to $84,000/year depending on the state.
The reason this matters specifically for working CHD adults: a cardiac procedure — even a "routine" cardiac catheterization — can easily cost $30,000–$80,000. Losing Medicaid because earnings crossed a threshold without proper benefits counseling can expose a working CHD adult to the full cost of that procedure. Before a CHD adult on SSI accepts a promotion, a raise, or a new job, a benefits counselor should model the exact 1619(b) threshold math to ensure Medicaid is not inadvertently surrendered.
For CHD adults whose SSDI (not SSI) is the basis for their disability benefits, Medicare — not Medicaid — is the insurance. SSDI recipients receive Medicare after a 24-month waiting period. Medicare covers cardiac hospitalizations and procedures under Part A (hospital) and Part B (outpatient) cost-sharing structures, which are more predictable but may still leave substantial cost-sharing on major procedures. An SNT distribution reserve for Medicare cost-sharing is a reasonable addition to the SNT budget for adults with complex CHD on SSDI.
ABLE accounts for CHD adults
For CHD adults who work and are not on SSI — or who have graduated off SSI due to earnings above 1619(b) thresholds — ABLE accounts provide a tax-advantaged savings vehicle for disability-related medical expenses. The 2026 annual ABLE contribution limit is $18,000 (standard) plus up to an additional $14,580 for employed contributors (ABLE-to-Work provision). ABLE accounts do not count against the SSI $2,000 resource limit up to $100,000, and investment growth within an ABLE account is tax-free when used for qualified disability expenses including medical care, preventive care, assistive technology, and cardiac procedures not fully covered by insurance.
For a CHD adult earning $50,000/year who needs periodic cardiac catheterizations, ABLE contributions over several years can build a reserve specifically designated for cardiac cost-sharing without disrupting SSI eligibility or other needs-based benefits.
SNT structure and distribution language for CHD families
Third-party SNT for children with complex CHD
A third-party Special Needs Trust for a child with complex CHD is funded by parents during their lifetime (from savings, investments, and SNT-beneficiary life insurance) and by inheritances directed from grandparents, aunts, uncles, and other family members who update their wills and beneficiary designations to name the SNT rather than the child directly. Any direct inheritance or gift above the SSI resource limit ($2,000) destroys SSI eligibility and can interrupt Medicaid for months. Once the SNT is established, all family gifting flows through it.
CHD-specific distribution language
An SNT for a CHD beneficiary should explicitly authorize the following categories of distributions, which are not always covered by standard SNT template language and which a corporate trustee without CHD knowledge may otherwise decline:
- Cardiac surgical procedures and associated ICU and step-down hospitalization costs, including at out-of-state or out-of-network centers of excellence
- Travel and lodging for the beneficiary and one caregiver to access ACHD specialist programs, cardiac catheterization, electrophysiology studies, and Fontan surveillance programs at specialized centers
- Hepatic monitoring and treatment related to Fontan-associated liver disease, including MRI, elastography, liver biopsy, interventional radiology, and oncology treatment if HCC develops
- Cardiac catheterization and transcatheter valve procedures, including travel to the small number of centers performing complex CHD catheter interventions
- Assistive devices and home modifications necessitated by reduced exercise tolerance or physical limitations from CHD (ramps, stair lifts, motorized mobility for severe functional limitation)
- Cardiac monitoring devices (loop recorders, event monitors) and related remote monitoring subscriptions
- Transplantation evaluation, listing, surgery, and post-transplant care including immunosuppression, biopsies, and rejection treatment
- Psychiatric care and medication management for anxiety and depression, which are substantially elevated in adolescents and young adults with CHD and in their parents2
- Educational supports, tutoring, and neuropsychological evaluations for CHD children with neurodevelopmental impact from cardiac surgery
SNT sizing guidance
SNT size depends heavily on where in the spectrum the child sits:
| CHD profile | Key cost drivers | SNT target range |
|---|---|---|
| Moderate complexity, good function, independent adult (repaired Fallot, coarctation) | Pulmonary valve replacement $80K–$200K; ACHD specialist access; LTD bridge if function declines | $150K – $500K |
| Complex biventricular CHD with partial work capacity (d-TGA, AV canal) | Reinterventions; neurodevelopmental supports; ACHD travel; Medicare gap cost-sharing | $500K – $1.5M |
| Single-ventricle / Fontan with stable function (ages 5–25) | Fontan reintervention; FALD surveillance; cardiac catheterization; potential transplant reserve | $1M – $3M |
| Fontan with FALD or declining ventricular function | Combined heart-liver transplant evaluation and surgery; lifelong immunosuppression; Fontan clinic access | $2M – $4M+ |
These ranges represent SNT supplemental reserves — amounts the SNT should hold to cover costs that Medicaid/Medicare/private insurance will not pay, including cost-sharing, out-of-network specialists, travel, and non-covered services. They are not total lifetime cost figures, which include the portions covered by government programs. A special needs financial planner running the lifetime care cost calculator should layer in the CHD intervention schedule alongside daily care costs to arrive at the full SNT funding target.
The adult CHD transition gap: financial consequences
Every pediatric cardiologist's practice eventually stops seeing patients who turn 18–25 (exact age varies by program). The transition to adult care — when it happens — requires finding one of the fewer than 500 board-certified ACHD cardiologists in the United States.1 Many CHD adults fall through the gap: they age out of pediatric care, cannot find an ACHD specialist, and go without appropriate cardiology follow-up for 5–10 years. Then, when a cardiac complication develops, it is diagnosed at a more advanced and more expensive stage.
The financial planning action item: when planning for a child with CHD, identify the ACHD program and cardiologist the child will transition to before the transition happens. If the nearest ACHD program is 200 miles away — a common situation outside major cities — the SNT distribution budget should account for periodic travel to that program for the beneficiary's entire adult life. This is not an edge-case cost; it is a structural cost for any Fontan adult or complex CHD adult who is not conveniently near one of the roughly 100 ACHD programs operating in the U.S.1
Three advisors every CHD family needs
The same three-professional coordination model that applies to most special needs planning applies with particular force to CHD:
- Special needs financial planner — models the SNT funding target across the surgical and medical cost trajectory; designs the insurance plan for parents; coordinates beneficiary designations and gift strategy with extended family; runs the 1619(b) math for working CHD adults
- Special needs attorney — drafts the SNT with CHD-specific distribution language; ensures the trust is properly structured as third-party (not first-party); coordinates with the estate attorney on parental wills and beneficiary designations; may also handle guardianship petition at age 18 if the child has neurodevelopmental impacts affecting legal capacity
- Benefits counselor (SSA-certified Work Incentives Planning and Assistance, WIPA) — models the 1619(b) threshold for working adults; plans the SSI-to-DAC transition timing if applicable; advises on ABLE account strategy and contribution limits; coordinates Medicaid category transitions during employment changes
Match with a special needs financial advisor
Special needs financial planning for CHD requires advisors who understand the full picture — SNT structure, life insurance for complex CHD families, surgical cost reserves, and benefits preservation for adults who work. We match CHD families with fee-only advisors who specialize in this intersection.
Related guides
- Lifetime Special Needs Care Cost Calculator — project CHD surgical costs alongside daily care costs, inflation-adjusted
- SNT Funding Target Calculator — estimate the trust balance needed to fund lifetime supplemental support
- Life Insurance for Special Needs Trusts — survivorship policies, ownership structure, and sizing
- Disabled Adult Child (DAC) Social Security Benefits — how a CHD adult inherits benefits on a parent's record
- SSI Work Incentives 2026 — Section 1619(b) Medicaid protection for working CHD adults
- First-Party vs. Third-Party SNT — which trust structure applies to CHD situations
- Inheritance Planning for Families with Special Needs Members — how grandparents and extended family can give without destroying SSI
- Down Syndrome Financial Planning — Down syndrome has 50–65% CHD comorbidity; planning overlap is substantial
Sources
- Adult Congenital Heart Association (ACHA); JACC 2026 (doi:10.1016/j.jacc.2026.01.021): board-certified ACHD cardiologist workforce <500 in U.S.; 2025 ACC/AHA/HRS/ISACHD/SCAI Guideline. Values verified June 2026.
- American Heart Association. Congenital Heart Defects — Impact and Statistics; CDC National Center on Birth Defects; ~40,000 CHD births/year, 2.4M+ U.S. adults with CHD; 25–35% neurodevelopmental comorbidity from cardiac surgery. Values verified June 2026.
- SSA Compassionate Allowances list (ssa.gov/compassionateallowances/conditions.htm): Hypoplastic Left Heart Syndrome listed; ~10-day processing with documentation. Verified June 2026.
- SSA Blue Book Listing 4.06, Symptomatic Congenital Heart Disease (revised 2022, Federal Register 2022-12980, effective 2023). Criteria: cyanosis at rest (hematocrit ≥55% or SpO2 <90% on two separate measurements ≥90 days apart); shunting with exercise intolerance ≤5 METs; or pulmonary arterial systolic pressure ≥70 mm Hg. ssa.gov/disability/professionals/bluebook/4.00-Cardiovascular-Adult.htm.
- SSA Blue Book Listing 104.06 (Cardiovascular — Childhood). ssa.gov/disability/professionals/bluebook/104.00-Cardiovascular-Childhood.htm.
- SurgeryCostGuide.com: open heart surgery average $150,000 in 2026, range $80,000–$250,000. JACC Pediatric CHD Surgery cost studies. Range for pulmonary valve replacement based on published AHA/JACC data and hospital cost studies. Values verified June 2026.
- JACC: Advances 2025 (doi:10.1016/j.jacadv.2025.101694); Circulation JACC 2020 (doi:10.1161/CIRCULATIONAHA.120.045597): FALD is universal in Fontan patients; annual HCC risk 1.5–5% in fibrotic/cirrhotic Fontan livers. Values verified June 2026.
All benefit amounts and thresholds reflect 2026 figures. SSA benefit rates, Medicare premiums, and 1619(b) thresholds adjust annually; confirm current-year values at ssa.gov before making benefit elections.